ECE2009 Poster Presentations Reproduction (50 abstracts)
Total ghrelin levels in obese and non-obese patients with polycystic ovary syndrome
Danica Pejkovic , Dragan Micic , Mirjana Sumarac-Dumanovic , Goran Cvijovic , Svetlana Zoric & Aleksandra Kendereski
Institute for Endocrinology, Diabetes and Diseases of Metabolism, Belgrade, Serbia.
Polycystic ovary syndrome (PCOS) is associated with adiposity and metabolic changes predisposing to insulin resistance. Because the recently discovered GH secretagogue, ghrelin is intimately involved in the control of appetite and weight regulation, we investigate ghrelin levels in non-obese and obese PCOS patients. Ten obese (BMI=32.50±1.57 kg/m2) and ten non-obese (BMI=20.45±0.51 kg/m2) patients with PCOS and their respective controls were evaluated. Fasting ghrelin was significantly lower in non-obese PCOS (51.82±26.83; P<0.05) as well as in obese PCOS (42.65±26.91; P<0.05) in comparison with controls (non-obese controls 120.11±58.42; obese-controls 96.33±37.34; P<0.05) matched for age and body mass index. In conclusion, women with PCOS had lower fasting ghrelin independently of their BMI, compared to the controls and there were no differences between fasting ghrelin levels among non-obese and obese women with PCOS. The ghrelin level in women with PCOS reflects the metabolic and hormonal changes which are characteristics of the syndrome.
Article tools
My recent searches
My recently viewed abstracts
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more